Moderna, Inc. (NASDAQ:MRNA) | WebDisclosure

Basculer en Français

11113	Companies
244616	Keywords
172650	Articles
131826	Press releases

Home
Companies
Moderna, Inc.

PRESS RELEASE

published on 09/17/2024 at 17:00, 2 years ago

Moderna Receives Health Canada Approval For Updated COVID-19 Vaccine Targeting KP.2 Variant Of SARS-COV-2 For Ages Six Months And Older
Moderna's SPIKEVAX® KP.2 variant COVID-19 vaccine authorized in Canada for 2024-2025 season to protect against COVID-19 strains. Delivery to begin promptly for vaccination campaigns

COVID-19 Vaccine Health Canada Moderna Spikevax Vaccination Campaigns
PRESS RELEASE

published on 09/17/2024 at 17:00, 2 years ago

Moderna reçoit l'approbation de Santé Canada pour le vaccin COVID-19 mis à jour ciblant le variant KP.2 du SRAS-COV-2 pour les personnes âgées de six mois et plus
Moderna Inc. obtient l'autorisation de Santé Canada pour son vaccin SPIKEVAX® mis à jour contre la COVID-19 pour le variant KP.2, renforçant la protection pendant les saisons automne-hiver 2024-2025

COVID-19 Moderna Inc. Santé Canada Vaccin SPIKEVAX®
BRIEF

published on 09/12/2024 at 12:05, 2 years ago

Moderna R&D Day Highlights Progress and Strategic Priorities

COVID-19 Vaccine Financial Outlook Vaccine Approvals Moderna Updates R&D Strategy
BRIEF

published on 09/12/2024 at 12:05, 2 years ago

La journée de recherche et développement de Moderna met en lumière les progrès et les priorités stratégiques

Perspectives Financières Vaccin Contre Le Covid-19 Mises À Jour De Moderna Stratégie De R&D Approbations De Vaccins
PRESS RELEASE

published on 09/12/2024 at 12:00, 2 years ago

Moderna R&D Day Highlights Progress and Strategic Priorities
Moderna, Inc. announces program updates focusing on ten product approvals through 2027, submission of next-gen COVID vaccine and flu/COVID combo vaccine in 2024, positive Phase 3 results for RSV vaccine, and cost efficiency improvements

Moderna Vaccine Phase 3 Results Product Approvals R&D Expense Reduction
BRIEF

published on 09/09/2024 at 13:05, 2 years ago

Moderna’s Canadian Manufacturing Facility Receives Drug Establishment License From Health Canada

Health Canada Moderna MRNA Vaccines Laval Facility Drug Establishment License
BRIEF

published on 09/09/2024 at 13:05, 2 years ago

L'usine canadienne de Moderna obtient une licence d'établissement de médicaments de Santé Canada

Vaccins À ARNm Moderne Santé Canada Établissement De Laval Licence D'établissement De Produits Pharmaceutiques
PRESS RELEASE

published on 09/09/2024 at 13:00, 2 years ago

Moderna’s Canadian Manufacturing Facility Receives Drug Establishment License From Health Canada
Moderna's Laval facility in Canada attains Drug Establishment License, a key step towards onshore mRNA vaccine production by 2025. This milestone boosts national vaccine supply

Canada Manufacturing Facility Moderna MRNA Vaccines Drug Establishment License
BRIEF

published on 09/05/2024 at 14:05, 2 years ago

EMA Recommends Authorization of Moderna's Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant JN.1

Authorization COVID-19 Vaccine Moderna EMA SARS-CoV-2 Variant
BRIEF

published on 09/05/2024 at 14:05, 2 years ago

L'EMA recommande l'autorisation du vaccin COVID-19 mis à jour de Moderna ciblant la variante JN.1 du SARS-CoV-2

Moderne Vaccin Contre Le Covid-19 Autorisation EMA Variante Du SARS-CoV-2

Accesswire

Published on 10/01/2026 at 22:00, 1 hour 3 minutes ago

Golden Minerals Company Announces New Management Appointments and Resignation of Mr. Pablo Castanos
Published on 10/01/2026 at 19:05, 3 hours 58 minutes ago

PEL 90 Participating Interest Exchange with Chevron
Published on 10/01/2026 at 18:05, 4 hours 58 minutes ago

Bocana Resources Corp. Provides a Corporate Update on Various Projects Currently Underway
Published on 10/01/2026 at 15:28, 7 hours 35 minutes ago

Core Critical Metals Corp. Announces Shareholder Approval of Plan of Arrangement
Published on 10/01/2026 at 14:30, 8 hours 33 minutes ago

Rio Grande Resources Secures Historical North Star and Little Wonder Mines and Confirms Mineralization With Returned Samples of Up to 35.9 g/t Gold and 248 g/t Silver

View all ACCESSWIRE

EQS Group

Published on 10/01/2026 at 20:45, 2 hours 18 minutes ago

Ditto Named a Product Leader in KuppingerCole Analysts Leadership Compass for Identity Verification
Published on 10/01/2026 at 20:30, 2 hours 33 minutes ago

Eleving Group prices EUR 200 million senior secured bonds at 9% in private placement – EUR 25 million exchange offer to follow
Published on 10/01/2026 at 18:55, 4 hours 8 minutes ago

Ondo Finance Announces Expansion of Ondo Intelligent Portfolios to Seven With New Magnificent 7, AI and Targeted Portfolios
Published on 10/01/2026 at 18:53, 4 hours 10 minutes ago

Holding(s) in Company
Published on 10/01/2026 at 18:35, 4 hours 28 minutes ago

Custodian Property Income REIT plc: Total Voting Rights

Les Echos

Published on 10/01/2026 at 19:00, 4 hours 3 minutes ago

AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions
Published on 10/01/2026 at 19:00, 4 hours 3 minutes ago

AMA CORP PLC réduit sa structure de coûts tout en préservant les fonctions clés de XpertEye
Published on 10/01/2026 at 18:40, 4 hours 22 minutes ago

Monthly disclosure of the total number of shares and voting rights - September 2026
Published on 10/01/2026 at 18:40, 4 hours 22 minutes ago

TF1 - Déclaration mensuelle des actions et droits de vote - Septembre 2026
Published on 10/01/2026 at 18:07, 4 hours 56 minutes ago

Covivio Hotels - Informations relatives au nombre total de droits de vote et d’actions composant le capital social

View all LES ECHOS COMFI WIRE